|
2024
|
Invention
|
Pyrimidopyridone and pteridone derivatives as inhibitors of the gcn2 kinase, compositions and use... |
|
|
Invention
|
Triazolopyridopyrimidine and dihydroimidazopyridopyrimidine derivatives as inhibitors of the gcn2... |
|
2023
|
Invention
|
Methods and systems for characterization, diagnosis, and treatment of cancer.
Disclosed herein a... |
|
|
Invention
|
Methods and systems for characterization, diagnosis, and treatment of cancer. Disclosed herein ar... |
|
|
Invention
|
Quinazoline derivatives as inhibitors of the gcn2 kinase, compositions and uses thereof. The pres... |
|
|
Invention
|
Isoquinoline derivatives as inhibitors of bax and/or bak, compositions and uses thereof.
The pre... |
|
|
Invention
|
Isoquinoline derivatives as inhibitors of bax and/or bak, compositions and uses thereof. The pres... |
|
2022
|
Invention
|
Mitochondrial dna prostate cancer marker and related systems and methods.
There is described her... |
|
|
Invention
|
Halo-substituted amino aza-heteroaryl compounds as inhibitors of the haematopoietic progenitor ki... |
|
|
Invention
|
Halo-substituted amino pyridine compounds as inhibitors of the haematopoietic progenitor kinase 1... |
|
|
Invention
|
Substituted amino aza-heteroaryl compounds as inhibitors of the haematopoietic progenitor kinase ... |
|
|
Invention
|
Substituted amino pyridine compounds as inhibitors of the haematopoietic progenitor kinase 1 (hpk... |
|
|
Invention
|
Isoindolinone aminopyrimidine compounds as inhibitors of nuak kinases, compositions and uses ther... |
|
|
Invention
|
Thienyl and cycloalkyl aminopyrimidine compounds as inhibitors of nuak kinases, compositions and ... |
|
2021
|
Invention
|
Nicotinamide phosphoribosyltransferase (nampt) inhibitor-conjugates and uses thereof.
The presen... |
|
|
Invention
|
Nicotinamide phosphoribosyltransferase (nampt) inhibitor-conjugates and uses thereof. The present... |
|
|
Invention
|
Molecular classifiers for prostate cancer.
There is described herein a method of predicting dise... |
|
|
Invention
|
Molecular classifiers for prostate cancer. There is described herein a method of predicting disea... |
|
2020
|
Invention
|
Unsaturated heterocycloalkyl and heteroaromatic acyl hydrazone linkers, methods and uses thereof.... |
|
|
Invention
|
Pan-cancer transcriptional signature.
There is described herein a pan-cancer transcriptional sig... |
|
|
Invention
|
Pan-cancer transcriptional signature. There is described herein a pan-cancer transcriptional sign... |
|
|
Invention
|
Amide-based proteolysis modulators of b-rapidly accelerated fibrosarcoma (braf) and associated us... |
|
2019
|
Invention
|
Compounds and methods for treating nematode infections. The present application relates to the tr... |
|
|
Invention
|
Substituted heteroaryls as inhibitors of the bcl6 btb domain protein-protein interaction. The pre... |
|
|
Invention
|
Inhibitors of the bcl6 btb domain protein-protein interaction and uses thereof. The present appli... |
|
2018
|
Invention
|
Tricyclic inhibitors of the bcl6 btb domain protein-protein interaction and uses thereof. The pre... |
|
|
Invention
|
Deuterated compounds as inhibitors of the bcl6 btb domain protein-protein interaction and/or as b... |
|
|
Invention
|
Novel deuterated compounds as inhibitors of the bcl6 btb domain protein-protein interaction and/o... |
|
|
Invention
|
Heterocyclic acyl hydrazone linkers, methods and uses thereof. The present application is directe... |
|
|
Invention
|
Quinolone compounds as inhibitors of the bcl6 btb domain protein-protein interaction and/or as bc... |
|
|
Invention
|
Novel quinolone compounds as inhibitors of the bcl6 btb domain protein-protein interaction and/or... |
|
|
Invention
|
Acyl hydrazone linkers, methods and uses thereof. The present application is directed to compound... |
|
|
Invention
|
Cancer risk based on tumour clonality. In an aspect, there is provided a method for diagnosing or... |
|
2017
|
Invention
|
Mirna prostate cancer marker. There is described herein a method of determining the likelihood of... |
|
|
Invention
|
Mitochondrial pna prostate cancer marker and related systems and methods. There is described here... |
|
|
Invention
|
Multi-modal prostate cancer marker.
There is described herein a method of prognosing and/or pred... |
|
2016
|
Invention
|
Gene signature of residual risk following endocrine treatment in early breast cancer. There is de... |
|
|
Invention
|
Targeting the histone pathway to detect and overcome anthracyclin resistance. There is provided h... |
